Marval Biosciences Raises $2.5 Million
Marval Biosciences, a San Diego-based developer of liposomal nanocarriers to deliver CT contrast agents, has raised $2.5 million in second-round funding. Backers include DFJ Frontier and DFJ Mercury. www.marvalbiosciences.com
16 October 2009•1 min read
